UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000013886
Receipt number R000015990
Scientific Title A phase II study of neoadjuvant epirubicin/cyclophosphamide (EC) followed by weekly nanoparticle albumin-bound paclitaxel with trastuzumab for HER2-positive breast cancer
Date of disclosure of the study information 2014/05/06
Last modified on 2016/05/11 10:02:17

No. Disposal Last modified on Item of update
1 Insert 2014/05/06 10:46:44
2 Update 2016/05/11 10:02:17 Name of primary person or sponsor
Institute
Organization
Organization